Pembrolizumab (Pembro) therapy vs best supportive care (BSC) in advanced hepatocellular carcinoma (HCC): KEYNOTE-240Richard S. Finn, Ann‐Lii Cheng, Ho Yeong Lim et al.|Annals of Oncology|2019Cited by 11